Screener
Integra LifeSciences IART Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Integra LifeSciences in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The source filing: Integra LifeSciences’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:03 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000917520-26-000058
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Total current liabilities | 330,881 | 455,981 |
| Long-term borrowings under senior credit facility | 1,736,105 | 1,729,556 |
| Long-term borrowings under securitization facility | 92,600 | — |
| Lease liability - operating leases | 162,660 | 163,059 |
| Deferred tax liabilities | 3,470 | 5,664 |
| Other liabilities | 194,397 | 204,278 |
| Total liabilities | 2,520,113 | 2,558,538 |
| Stockholders’ equity: |
Item 1. Financial Statements
FAQ
- What is Integra LifeSciences's operating lease liabilities?
- Integra LifeSciences (IART) reported operating lease liabilities of $162.66M in Q2 2026.
- How has Integra LifeSciences's operating lease liabilities changed year-over-year?
- Integra LifeSciences's operating lease liabilities increased by 2.1% year-over-year, from $159.27M to $162.66M.
- What is the long-term trend for Integra LifeSciences's operating lease liabilities?
- Over 5 years (2020 to 2025), Integra LifeSciences's operating lease liabilities has grown at a 13.1% compound annual growth rate (CAGR), from $88.12M to $163.06M.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.
Ask your AI about Integra LifeSciences's operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude